To investigate whether the anticancer effect of gemcitabine in BLCA involves the MYCN-PKIB-PKA-HSP27 axis, we detected the protein expression of MYCN, PKIB, and HSP27 in gemcitabine-treated BLCA cells. This evidence concerns the gene MYCN and bladder transitional cell carcinoma.